Education
About Us
Working with TipRanks
Follow Us
Nanobiotix (NBTX)
NASDAQ:NBTX
Total Valuation
Nanobiotix has a market cap or net worth of $158.26M. The enterprise value is .
Market Cap$158.26M
Enterprise Value
Share Statistics
Nanobiotix has 47.13M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47.13M
Owned by Insiders
Owned by Instutions12.60%
Financial Efficiency
Nanobiotix’s return on equity (ROE) is 21.53 and return on invested capital (ROIC) is -54.77%.
Return on Equity (ROE)2152.93%
Return on Assets (ROA)-42.28%
Return on Invested Capital (ROIC)-54.77%
Return on Capital Employed (ROCE)-60.83%
Revenue Per Employee$383,672.727
Profits Per Employee-$304,300
Employee Count110
Asset Turnover0.39
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nanobiotix is -6.10. Nanobiotix’s PEG ratio is 0.18.
PE Ratio-6.10
PS Ratio6.69
PB Ratio-131.29
Price to Fair Value-131.29
Price to FCF-18.90
Price to Operating Cash Flow-19.41
PEG Ratio0.18
Income Statement
In the last 12 months, Nanobiotix had revenue of $42.20M and earned -$33.47M in profits. Earnings per share was -$0.76.
Revenue$42.20M
Gross Profit$42.20M
Operating Income-$25.06M
Pretax Income-$33.21M
Net Income-$33.47M
EBITDA-21.83M
Earnings Per Share (EPS)-0.76
Cash Flow
In the last 12 months, operating cash flow was -$1.04M and capital expenditures -$494.00K, giving a free cash flow of -$1.53M billion.
Operating Cash Flow-$1.04M
Free Cash Flow-$1.53M
Free Cash Flow per Share-$0.03
Dividends & Yields
Nanobiotix pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-5.29%
Earnings Yield-16.40%
Stock Price Statistics
Beta0.14
52-Week Price Change-40.43%
50-Day Moving Average3.55
200-Day Moving Average4.21
Relative Strength Index (RSI)47.52
Average Volume (3m)14.24K
Important Dates
Nanobiotix upcoming earnings date is May 14, 2025, During Market Hours.
Last Earnings DateApr 2, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Nanobiotix as a current ratio of 1.75, with Debt / Equity ratio of -27.42
Current Ratio1.75
Quick Ratio1.75
Debt to Market Cap0.19
Net Debt to EBITDA1.04
Interest Coverage Ratio-3.35
Taxes
In the past 12 months, Nanobiotix has paid $261.00K in taxes.
Income Tax$261.00K
Effective Tax Rate-0.30%
Enterprise Valuation
Nanobiotix EV to EBITDA ratio is -9.18, with an EV/FCF ratio of -16.97.
EV to Sales6.00
EV to EBITDA-9.18
EV to Free Cash Flow-16.97
EV to Operating Cash Flow-17.42
Balance Sheet
Nanobiotix has $66.33M in cash and marketable securities with $49.17M in debt, giving a net cash position of -$17.17M billion.
Cash & Marketable Securities$66.33M
Total Debt$49.17M
Net Cash-$17.17M
Net Cash Per Share-$0.36
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 100.00%, with operating margin of -73.96%, and net profit margin of -109.64%.
Gross Margin100.00%
Operating Margin-73.96%
Pretax Margin-109.31%
Net Profit Margin-109.64%
EBITDA Margin-65.42%
EBIT Margin-66.94%
Analyst Forecast
The average price target for Nanobiotix is $6.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.83
Price Target Upside105.11%
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast54.68%